Anti-BCMA CAR-T therapy for multiple myeloma with extramedullary disease: A case report and review of the literature.

Shi H, Zhang M, Su Y, Liu J, Guo J, Liu M, Ma Q

Open source

DOI
10.1097/md.0000000000038541
Published
2024 Jun 28
Container
Medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1097/md.0000000000038541,
  title = {Anti-BCMA CAR-T therapy for multiple myeloma with extramedullary disease: A case report and review of the literature.},
  author = {Shi H and Zhang M and Su Y and Liu J and Guo J and Liu M and Ma Q},
  year = {2024},
  journal = {Medicine},
  doi = {10.1097/md.0000000000038541},
  url = {https://doi.org/10.1097/md.0000000000038541}
}

RIS

TY  - JOUR
TI  - Anti-BCMA CAR-T therapy for multiple myeloma with extramedullary disease: A case report and review of the literature.
AU  - Shi H
AU  - Zhang M
AU  - Su Y
AU  - Liu J
AU  - Guo J
AU  - Liu M
AU  - Ma Q
PY  - 2024
JO  - Medicine
DO  - 10.1097/md.0000000000038541
UR  - https://doi.org/10.1097/md.0000000000038541
ER  - 

APA

H, S., M, Z., Y, S., J, L., J, G., M, L., & Q, M. (2024). Anti-BCMA CAR-T therapy for multiple myeloma with extramedullary disease: A case report and review of the literature.. Medicine. https://doi.org/10.1097/md.0000000000038541

Source records